New partnership to take potential treatment for motor neuron disease (MND) into clinical trials
Researchers from the University of Sheffield’s Institute for Translational Neuroscience (SITraN) have been awarded a $700,000 drug development grant to progress a potential targeted therapy for motor neuron disease (MND) into clinical trials. The grant, awarded by Australian charity FightMND, will support SITraN’s partnership with Aclipse Therapeutics to progress a disease-modifying drug candidate – M102…